TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
PBLS

Parabilis Medicines, Inc.

Healthcare · Biotechnology

28.40$ +2.7% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns Parabilis Medicines, Inc. (PBLS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 67.3% of the shares are freely tradable; institutional investors hold 58.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 58.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 7.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 67.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 7.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 122Mio.

Largest Shareholders

Institutions

Institutions PBLS
Name Stake (%) Shares Change (%) Date
RA Capital Management, LLC 23.42 28,933,371 +0.0 06/30/2026
FMR Inc 8.33 10,292,735 +0.0 06/30/2026
ARCH VENTURE CORP 5.19 6,412,780 +0.0 06/30/2026
venBio Partners LLC 4.26 5,266,697 +0.0 06/30/2026
Alphabet Inc 3.98 4,919,498 +0.0 06/30/2026
Nextech Invest, Ltd. 3.77 4,663,176 +0.0 06/30/2026
Cormorant Asset Management, LLC 3.74 4,615,612 +0.0 06/30/2026
Regeneron Pharmaceuticals Inc 3.37 4,166,666 +0.0 09/30/2026
Siren, L.L.C. 2.42 2,992,259 +0.0 06/30/2026
Farallon Capital Management, L.L.C. 1.92 2,368,200 +0.0 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?